IP Library Patent Application 13950235
Patent Application
App. No. 13/950,235

Injectable Nanoparticulate Olanzapine Formulations

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
13/950,235
Abstract

Described are injectable formulations of particulate olanzapine that produce a prolonged duration of action upon administration, and methods of making and using such formulations. The injectable formulations comprise particulate olanzapine.

Claims (6)

1 . An injectable depot composition comprising:

(a) particles of olanzapine its salts, hydrates, solvates, polymorphs, co-crystalline, prodrugs, or analogues thereof, the particles having an effective average particle size of less than 5000 nm;

(b) at least one surface stabilizer adsorbed on the surface of the particles; and

(c) a pharmaceutically acceptable carrier,

wherein the injectable depot has a therapeutic efficacy of about one week or greater.

2 - 28 . (canceled)